97 related articles for article (PubMed ID: 2468256)
1. Prolonged limb allograft survival with short-term treatment with FK-506 in rats.
Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
Transplant Proc; 1989 Feb; 21(1 Pt 3):3191-3. PubMed ID: 2468256
[TBL] [Abstract][Full Text] [Related]
2. [Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)].
Weigao C
Fukuoka Igaku Zasshi; 1996 Sep; 87(9):197-205. PubMed ID: 8913057
[TBL] [Abstract][Full Text] [Related]
3. Experimental studies of vascularized allogeneic limb transplantation in the rat using a new immunosuppressive agent, FK-506: morphological and immunological analysis.
Kuroki H; Ikuta Y; Akiyama M
Transplant Proc; 1989 Feb; 21(1 Pt 3):3187-90. PubMed ID: 2468255
[No Abstract] [Full Text] [Related]
4. Effects of inhaled FK 506 on the suppression of acute rejection after lung transplantation: use of a rat orthotopic lung transplantation model.
Ingu A; Komatsu K; Ichimiya S; Sato N; Hirayama Y; Morikawa M; Abe T
J Heart Lung Transplant; 2005 May; 24(5):538-43. PubMed ID: 15896750
[TBL] [Abstract][Full Text] [Related]
5. Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival.
Kuroki H; Bean MA; Ikuta Y; Akiyama M; Burgess EM
Transplant Proc; 1993 Feb; 25(1 Pt 1):658-61. PubMed ID: 7679833
[No Abstract] [Full Text] [Related]
6. Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
Fealy MJ; Umansky WS; Bickel KD; Nino JJ; Morris RE; Press BH
Ann Surg; 1994 Jan; 219(1):88-93. PubMed ID: 7507657
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival.
Kuroki H; Bean MA; Ikuta Y; Burgess EM
Transplant Proc; 1991 Dec; 23(6):3282-4. PubMed ID: 1721436
[No Abstract] [Full Text] [Related]
8. Effects of a novel immunosuppressive agent, FK-506, on islet allograft survival in the rat.
Yasunami Y; Ryu S; Kamei T; Konomi K
Transplant Proc; 1989 Feb; 21(1 Pt 3):2720. PubMed ID: 2468234
[No Abstract] [Full Text] [Related]
9. Prolongation of canine renal allograft survival by treatment with FK-506.
Ochiai T; Nagata M; Nakajima K; Sakamoto K; Asano T; Isono K
Transplant Proc; 1987 Oct; 19(5 Suppl 6):53-6. PubMed ID: 2445075
[No Abstract] [Full Text] [Related]
10. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
11. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
[TBL] [Abstract][Full Text] [Related]
12. Heterotopic heart transplantation in the rat receiving FK-506.
Lim SM; Thiru S; White DJ
Transplant Proc; 1987 Oct; 19(5 Suppl 6):68-70. PubMed ID: 2445080
[No Abstract] [Full Text] [Related]
13. Effect of single-dose administration of FK-506 on allogeneic limb transplantation in rats: is there an optimal timing of its administration?
Gohda T; Iwasaki N; Yoshioka C; Minami A
Plast Reconstr Surg; 2003 Apr; 111(5):1653-8. PubMed ID: 12655211
[TBL] [Abstract][Full Text] [Related]
14. Experimental limb transplantation, part I: identification of an effective tapered triple combination immunosuppressive regime.
Ayrout C; Lanzetta M; Chunasuwankul R; Gal A; Owen ER
Transplant Proc; 2004 Apr; 36(3):669-74. PubMed ID: 15110627
[TBL] [Abstract][Full Text] [Related]
15. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
[TBL] [Abstract][Full Text] [Related]
16. Nerve regeneration of vascularized rat limb allograft and functional recovery of long-term graft survivals treated by short course of FK 506 or cyclosporine.
Kuroki H; Ikuta Y
Transplant Proc; 1995 Feb; 27(1):348-50. PubMed ID: 7533405
[No Abstract] [Full Text] [Related]
17. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats].
Lü L; Zhang W; Sun X
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):25-8. PubMed ID: 11835769
[TBL] [Abstract][Full Text] [Related]
18. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats.
Ochiai T; Nakajima K; Nagata M; Hori S; Asano T; Isono K
Transplantation; 1987 Dec; 44(6):734-8. PubMed ID: 2447689
[TBL] [Abstract][Full Text] [Related]
19. Experimental limb transplantation, part II: excellent return of function and indefinite survival after withdrawal of immunosuppression.
Lanzetta M; Ayrout C; Gal A; Dereli Z; Wright B; Lauer C; Owen ER
Transplant Proc; 2004 Apr; 36(3):675-9. PubMed ID: 15110628
[TBL] [Abstract][Full Text] [Related]
20. Recipient FK506 pretreatment regimens in rat small bowel transplantation: allograft survival, function, and systemic infection.
Guo WH; Tian L; Yuen ZW; Chan KL; Wo JY; Nicholls G; Dallman M; Tam PK
J Pediatr Surg; 2000 Nov; 35(11):1600-5. PubMed ID: 11083432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
